Association of Helicobacter pylori infection with acute myocardial infarction

Coronary Artery Disease

Volumn 22, Issue 1, 2011, Pages 6-11

  Khodaii, Zohreh ^a   Vakili, Hosain ^a   Ghaderian, Sayyed Mohammad Hossein ^a   Najar, Reza Akbarzadeh ^a   Panah, Akram Sadat Tabatabaei ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

acute myocardial infarction; cardiovascular disease; cytotoxin associated protein strain; Helicobacter pylori; inflammation

Indexed keywords

C REACTIVE PROTEIN; CAGA PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; VIRULENCE;

EID: 78650791312     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283402360     Document Type: Article

References (40)

1. Ballantyne CM, Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 2005; 6:21-29.
2. De Maat MP, Trion A. C-reactive protein as a risk factor versus risk marker. Curr Opin Lipidol 2004; 15:651-657.
3. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006; 113:929-937.
4. Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000; 101:252-257.
5. Filep JG. Cardiovascular disease and inflammation: novel biomarkers of inflammation and endothelial activation. Vasc Dis Prev 2005; 2:191-203.
6. Kaplan M, Yavuz SS, Cinar B, Koksal V, Kut MS, Yapici F, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis 2006; 10:116-123.
7. Ozdogru I, Kalay N, Dogan A, Inanc MT, Kaya MG, Topsakal R, et al. The relationship between Helicobacter pylori IgG titre and coronary atherosclerosis. Acta Cardiol 2007; 62:501-505.
8. Kowalski M, Pawlik M, Konturek JW, Konturek SJ. Helicobacter pylori infection in coronary artery disease. J Physiol Pharmacol 2006; 57: 101-111.
9. Gunn M, Stephens JC, Thompson JR, Rathbone BJ, Samani NJ. Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000; 84:267-271.
10. Radosz-Komoniewska H, Bek T, Jozwiak J, Martirosian G. Pathogenicity of Helicobacter pylori infection. Clin Microbiol Infect 2005; 11:602-610.
11. Achtman M, Azuma T, Berg DE, Ito Y, Morelli G, Pan ZJ, et al. Recombination and clonal groupings within Helicobacter pylori from different geographical regions. Mol Microbiol 1999; 32:459-470.
12. Xiang Z, Censini S, Bayeli P, Telford J, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63:94-98.
13. Peek RMJ, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, et al. Heightened inflammatory response and cytokine expression in vivo to cagA + Helicobacter pylori strains. Lab Invest 1995; 73:760-770. (Pubitemid 26002335)
14. Ching CK, Wong BC, Kwok E, Ong L, Covacci A, Lam SK. Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996; 91:949-953.
15. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-2115.
16. Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, et al. Analysis of serum antibody profile against H. pylori VacA and CagA antigens in Turkish patients with duodenal ulcer. World J Gastroenterol 2006; 12:6869-6873.
17. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350:430-436.
18. Grabczewska Z, Nartowicz E, Kubica J, Rosc D. Endothelial function parameters in patients with unstable angina and infection with Helicobacter pylori and Chlamydia pneumoniae. Eur J Intern Med 2006; 17:339-342.
19. Diomedi M, Stanzione P, Sallustio F, Leone G, Renna A, Misaggi G, et al. Cytotoxin-associated gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke. Helicobacter 2008; 13:525-531.
20. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005; 45:1219-1222.
21. Zhu J, Quyyumi AA, Muhlestein JB, Nieto FJ, Horne BD, Zalles-Ganley A, et al. Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am J Cardiol 2002; 89:155-158.
22. Mach F, Sukhova GK, Michetti M, Libby P, Michetti P. Influence of Helicobacter pylori infection during atherogenesis in vivo in mice. Circ Res 2002; 90:1-4.
23. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE. DNA diversity among clinical isolates of Helicobacter pylori detected by PCRbased RAPD fingerprinting. Nucleic Acids Res 1992; 20:5137-5142.
24. Ghiara P, Marchetti M, Blaser MJ, Tummuru MK, Cover TL, Segal ED, et al. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun 1995; 63:4154-4160.
25. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 1997; 41:442-451.
26. Briede JJ, Pot RG, Kuipers EJ, Van Vliet AH, Kleinjans JC, Kusters JG. The presence of the cag pathogenicity island is associated with increased superoxide anion radical scavenging activity by Helicobacter pylori. FEMS Immunol Med Microbiol 2005; 44:227-232.
27. Zhang S, Guo Y, Ma Y, Teng Y. Cytotoxin-associated gene-A-seropositive virulent strains of Helicobacter pylori and atherosclerotic diseases: A systematic review. Chin Med J (Engl) 2008; 121:946-951.
28. Lenzi C, Palazzuoli A, Giordano N, Alegente G, Gonnelli C, Campagna MS, et al. H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease. World J Gastroenterol 2006; 12:7815-7820.
29. Khodaii Z, Ghaderian SM, Akbarzadeh Najar R, Nejati H, Tabatabaei Panah AS. CagA and vacA status and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease. Ir J Med Sci 2010. doi: 10.1007/s11845-010-0548-5. [Epub ahead of print]
30. Crabtree JE. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 1996; 10:29-37.
31. Correa P. The epidemiology and pathogenesis of chronic gastritis: Three etiologic entites. Front Gastrointest Res 1980; 6:98-108.
32. Correa P. Chronic gastritis: A clinico-pathological classification. Am J Gastroenterol 1988; 83:504-509.
33. Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocytegenerated oxidants in carcinogenesis. Blood 1990; 76:655-663.
34. Gabrielli M, Santoliquido A, Cremonini F, Cicconi V, Candelli M, Serricchio M, et al. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke. Eur Heart J 2004; 25:64-68.
35. Diomedi M, Pietroiusti A, Silvestrini M, Rizzato B, Cupini LM, Ferrante F, et al. CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke. Neurology 2004; 63:800-804.
36. Niccoli G, Franceschi F, Cosentino N, Giupponi B, De Marco G, Merra G, et al. Coronary atherosclerotic burden in patients with infection by CagApositive strains of Helicobacter pylori. Coron Artery Dis 2010; 21:217-221.
37. Tekin IO, Pocan B, Borazan A, Ucar E, Kuvandik G, Ilikhan S, et al. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients. Ren Fail 2008; 30:219-225.
38. Rosvall M, Engstrom G, Berglund G, Hedblad B. C-reactive protein, established risk factors and social inequalities in cardiovascular disease - the significance of absolute versus relative measures of disease. BMC Public Health 2008; 8:189.
39. Damas JK, Waehre T, Yndestad A, Gullestad L, Aukrust P. Atherosclerotic plaque stabilization-potential role for immunomodulatory therapy. Vasc Dis Prev 2004; 1:17-31.
40. Chen WQ, Zhang L, Liu YF, Chen L, Ji XP, Zhang M, et al. Prediction of atherosclerotic plaque ruptures with high-frequency ultrasound imaging and serum inflammatory markers. Am J Physiol Heart Circ Physiol 2007; 293:2836-2844.